Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Woodside updates cost expectations ahead of first-half results

(Sharecast News) - Woodside flagged anticipated first-half production costs of $710m to $780m in an update on Thursday, with royalties, excise and levies expected to amount to $180m to $210m. The company said the depreciation and amortisation of oil and gas properties was projected to be between $1.85bn and $1.95bn, not including depreciation of lease assets.

Other income was estimated to lie between $250m and $380m, bolstered by profits from the sell-down of Woodside's Scarborough project to LNG Japan.

Net finance costs were forecast to range from $50m to $55m.

A significant point was the projected income tax expense, with the statutory income tax expense expected to be between $100m and $200m, while the underlying expense was forecasted at $400m to $500m.

The firm said the statutory income tax expense reflected the first-time recognition of a net deferred tax asset related to the Sangomar project, along with other tax accounting adjustments.

It said the tax adjustments were anticipated to substantially reduce Woodside's effective income tax rate for the first half of 2024, making it considerably lower than the full-year 2023 statutory and underlying rates, which were 27.5% and 31%, respectively.

Woodside said the adjustments would not, however, affect its tax payments for the period.

At 0841 BST, shares in Woodside Energy Group were up 0.31% in London, at 1,308p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it has appointed Ajay Dhankhar as chief corporate development & strategy officer with immediate effect.
Oxford Biomedica acquires last 10pc stake in US subsidiary
(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.
PPHE acquiring prime London site for hotel development
(Sharecast News) - PPHE Hotel Group has announced the acquisition of a prime development site near the City of London, where it plans to build its first Radisson RED select service hotel in the capital.
Norcros to end tile production in South Africa
(Sharecast News) - Norcros announced on Monday that it will shut down manufacturing at Johnson Tiles South Africa at the end of June, following the conclusion of a strategic review.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.